诺瓦瓦克斯医药(NVAX)股价今日盘中出现了大跌5.12%的情况,引发市场广泛关注。新闻显示,这可能与美国当选总统特朗普任命著名疫苗反对派人士小罗伯特-肯尼迪(Robert F. Kennedy Jr.)出任美国卫生与公共服务部部长有关。
报道指出,肯尼迪曾多次散布有关疫苗与自闭症相关的错误信息,且持有非理性疫苗观点。他的任命引发了市场对特朗普政府未来在医疗保健和生物技术领域政策走向的担忧,预计会对疫苗和生物技术公司的业务发展产生一定影响。
这一消息的曝光立即引发了疫苗和生物技术股大幅下跌,除诺瓦瓦克斯医药外,Covid-19疫苗企业莫德纳、辉瑞和BioNTech股价在盘前均出现不同程度下跌。分析师认为,这反映出投资者对未来药品监管和研发支持放缓的忧虑。业界专家也呼吁重视这一任命可能对全球疫苗接种工作带来的冲击。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.